Protagonist Therapeutics Jumps 6.3% Amid Sector-Wide Rally
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence Protagonist Therapeutics surged 6.3% on Tuesday, riding a broad rally across biotechnology sector peers that lifted the company’s shares to $104.16. The Nasdaq-listed biotech closed with a market capitalization of $6.8 billion as…







